RESEARCH-USE BIOSIMILAR ANTIBODY
Pembrolizumab
Monoclonal antibody · IgG4
Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-004
CATALOG NUMBERSC-BS-004
MOLECULAR WEIGHTApprox. 145.24 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.